Clinical Trial Update: p16 Methylation for Smoking Cessation [NA]

View source ↗

Summary

The Duke University trial on p16 methylation for smoking cessation has completed; the update does not report outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Tobacco Use Disorder

Snippet

Sponsor: Duke University | Conditions: Tobacco Use Disorder, Smoking Cessation | NA | Status: COMPLETED